EATON VANCE $39.32

down -0.86


19/6/2013 04:19 PM  |  NYSE : EV  |  Industries : Finance and Insurance / Other Financial Investment Activities
Last Trade: 39.32
Trade Time: Jun 19 4:08 PM Eastern Daylight Time
Change: -0.86 (-2.14 %)
Prev Close: 40.18
Open: 40.10
Bid: 39.31
Ask: 39.54
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get EV Trend Analysis - it has outperformed the S&P 500 by 31%

ETF Alternatives



People viewing EV also viewed: , , , ,

Competitors

Ticker Name Volume % Change
CSGJ CHINA SHUANGJI CEMENT 1.2K +199.00%
CHIL CHILL TECH INDUSTRIES 50.0K +4.83%
NNA+ NAVIOS MARITIME ACQSTN WARRANT 200.0 +2.98%
AVNE AVENTURA EQUITIES 10.7K +0.76%
NTUR NATURAL BLUE RESOURCES 70.7K +0.67%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
3/27/2013 HYLTON LAURIE G Chief Financial Officer -2,423 $41.26 -1.58%
3/27/2013 HYLTON LAURIE G Chief Financial Officer -23,278 $41.11 -15.45%
3/27/2013 BERMAN ANN E Director -4,902 $40.82 -100.00%
3/27/2013 HYLTON LAURIE G Chief Financial Officer 40,778 $17.09 36.30%
3/19/2013 BERMAN ANN E Director -8,197 $40.51 -100.00%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (EV), click here.

EV Stock Analysis

  1. MediciNova Presents MN-166 Data - Analyst Blog

    MediciNova announced the presentation of preliminary data from a phase Ib study of MN-166 for the treatment of methamphetamine addiction
  2. Teva to Acquire MicroDose Therapeutx - Analyst Blog

    This deal is in line with Teva's strategy of strengthening its position in the respiratory therapeutic area.
  3. $2.15B Settlement for Pfizer's Protonix - Analyst Blog

    While Teva will make a payment of $1.6 billion, Sun Pharma will pay the remaining $550 million.
  4. SGEN Starts Adcetris Phase I/II Study - Analyst Blog

    Seattle Genetics commenced a phase I/II study to evaluate Adcetris in combination with Teva Pharma's Treanda (bendamustine) for Hodgkin lymphoma (HL) patients after first relapse
  5. GE Augments Entravision's Liquidity - Analyst Blog

    GE Capital's Telecom, Media and Technology financing business recently served as administrative agent for a $405 million-worth credit facility for Entravision.
  6. CBS Pinned to Neutral - Analyst Blog

    We have maintained our long-term Neutral recommendation on CBS Corporation.
Free Reports
  1. Forbes Wolfe Nanotech Report Nanotech 101

    Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!
  2. Get 4 quotes FREE - Refinance and Save

    Instant matching service with top lenders.
  3. Five Chart Patterns You Need to Know!

    Time tested chart patterns for maximum profits. Learn more in this free report from ChartAdvisor.com.
Marketplace
Trading Center